• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

(4-Nitrophenyl)methanesulfonohydrazide and Its Significance in Modern Chemical Research

(4-Nitrophenyl)methanesulfonohydrazide (CAS No. 49777-56-2) is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its nitro and hydrazide functional groups, serves as a versatile intermediate in the synthesis of various pharmacologically active molecules. Its unique structural properties make it particularly valuable in the development of novel therapeutic agents targeting a range of diseases.

The molecular structure of (4-Nitrophenyl)methanesulfonohydrazide consists of a phenyl ring substituted with a nitro group at the 4-position and a methanesulfonylhydrazide moiety at the 1-position. This arrangement imparts distinct reactivity, making it an attractive candidate for further functionalization. The nitro group can undergo reduction to form an amine, while the hydrazide functionality can participate in condensation reactions with carbonyl compounds, leading to the formation of hydrazones. These transformations are pivotal in medicinal chemistry, enabling the construction of complex molecular architectures.

In recent years, (4-Nitrophenyl)methanesulfonohydrazide has been explored in the context of developing new antitumor agents. The hydrazide moiety is known to react with aldehydes and ketones to produce hydrazones, which have demonstrated cytotoxic effects against various cancer cell lines. For instance, studies have shown that derivatives of this compound can induce apoptosis in malignant cells by interfering with critical signaling pathways involved in cell proliferation and survival. The presence of the nitro group further enhances its potential as a bioactive molecule, as it can be metabolically converted into an amine, which may exhibit additional pharmacological effects.

Moreover, (4-Nitrophenyl)methanesulfonohydrazide has found applications in the synthesis of inhibitors targeting bacterial enzymes. The sulfonamide moiety is well-known for its ability to disrupt bacterial cell wall synthesis and metabolic processes. Researchers have leveraged this property to design molecules that inhibit key enzymes such as dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS), which are essential for bacterial folate metabolism. By incorporating the hydrazide group into these sulfonamide-based structures, scientists have been able to enhance binding affinity and selectivity, leading to more effective antimicrobial agents.

The compound's utility extends beyond its role as a synthetic intermediate; it also serves as a probe for understanding reaction mechanisms in organic chemistry. The nitro group's redox properties allow it to participate in both oxidation and reduction reactions, providing insights into electron transfer processes. This characteristic makes (4-Nitrophenyl)methanesulfonohydrazide a valuable tool for studying catalytic systems and developing new synthetic methodologies.

In conclusion, (4-Nitrophenyl)methanesulfonohydrazide (CAS No. 49777-56-2) is a multifaceted compound with significant implications in pharmaceutical research and chemical biology. Its unique structural features enable diverse applications, from the development of antitumor agents to the design of novel antimicrobial drugs. As research continues to uncover new therapeutic targets and synthetic strategies, this compound is poised to play an increasingly important role in advancing medical science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)